BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1258 related articles for article (PubMed ID: 33371891)

  • 1. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
    Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
    Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
    Pang W; Chen M; Qin Y
    BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deep neural network approach to predicting clinical outcomes of neuroblastoma patients.
    Tranchevent LC; Azuaje F; Rajapakse JC
    BMC Med Genomics; 2019 Dec; 12(Suppl 8):178. PubMed ID: 31856829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular within and between score for drug response prediction in cancer cell lines.
    Wang S; Li J
    Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of network features for the prediction of breast cancer metastasis.
    Adnan N; Liu Z; Huang THM; Ruan J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):40. PubMed ID: 32241278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convolutional neural network models for cancer type prediction based on gene expression.
    Mostavi M; Chiu YC; Huang Y; Chen Y
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):44. PubMed ID: 32241303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.
    Kishore A; Venkataramana L; Prasad DVV; Mohan A; Jha B
    Med Biol Eng Comput; 2023 Nov; 61(11):2895-2919. PubMed ID: 37530887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Drug Response Prediction by Using a Lq Penalized Network-Constrained Logistic Regression Method.
    Huang HH; Dai JG; Liang Y
    Cell Physiol Biochem; 2018; 51(5):2073-2084. PubMed ID: 30522095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring potential circRNA biomarkers for cancers based on double-line heterogeneous graph representation learning.
    Zhang Y; Wang Z; Wei H; Chen M
    BMC Med Inform Decis Mak; 2024 Jun; 24(1):159. PubMed ID: 38844961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer.
    Chereda H; Leha A; Beißbarth T
    Artif Intell Med; 2024 May; 151():102840. PubMed ID: 38658129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma.
    Shao B; Bjaanæs MM; Helland Å; Schütte C; Conrad T
    PLoS One; 2019; 14(1):e0204186. PubMed ID: 30703089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data.
    Xu D; Zhang J; Xu H; Zhang Y; Chen W; Gao R; Dehmer M
    BMC Genomics; 2020 Sep; 21(1):650. PubMed ID: 32962626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
    Liu Q; Xie L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAEROF: an ensemble approach for large-scale drug-disease association prediction by incorporating rotation forest and sparse autoencoder deep neural network.
    Jiang HJ; Huang YA; You ZH
    Sci Rep; 2020 Mar; 10(1):4972. PubMed ID: 32188871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.
    Grimes M; Hall B; Foltz L; Levy T; Rikova K; Gaiser J; Cook W; Smirnova E; Wheeler T; Clark NR; Lachmann A; Zhang B; Hornbeck P; Ma'ayan A; Comb M
    Sci Signal; 2018 May; 11(531):. PubMed ID: 29789295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.